Melanoma
-
Forward Look
What’s Next? Summer 2021Using fecal transplants to improve immunotherapy response
by Natalie Slivinski
-
Facts and Stats
Categorizing Skin CancerA knowledge of the different types of skin cancer can help you remain vigilant.
by Bradley Jones
-
How Long Do Immunotherapy Side Effects Last?For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.
by Anna Goshua
-
Worth the WaitNeoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
by Sharon Tregaskis
-
Our Own WordsPeople with cancer and their loved ones find ways for their voices to be heard without filters.
by Bradley Jones
-
Survivor Profile
Still in the GameESPN reporter Holly Rowe worked through melanoma treatment.
by Lindsey Konkel
-
Q&A
Dissecting Mental IllnessNeuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain.
by Marci A. Landsmann
-
Pembrolizumab Shows Further Promise for MelanomaIn a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.
by Brad Jones
-
Forward Look
Tackling Drug ResistanceResearchers are studing new ways to keep treatments working longer.
by Stephen Ornes
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
